Data from recent research, including a March 2024 McKinsey survey, shows that more than 70% of healthcare groups—such as hospitals, clinics, payers, and health technology companies—are at different stages of using generative AI. Nearly 60% of those already using AI say they either see or expect a positive return on investment (ROI). This shows some hope among healthcare organizations about the benefits of AI.
Many organizations (59%) prefer to work with third-party vendors to create custom generative AI solutions instead of building these technologies completely on their own. This is because ready-made AI products may not meet the specific rules or work methods needed by healthcare providers, especially in the U.S. where laws like HIPAA (Health Insurance Portability and Accountability Act) must be followed carefully.
In fact, only 17% of organizations currently use ready-made generative AI products, while 24% are developing AI skills inside their teams. Among those not yet using generative AI, 41% plan to buy ready-made products eventually, but worries about risk stop many from starting right away.
The main challenge reported by 57% of healthcare leaders is managing risks related to generative AI use. Generative AI can produce mistakes, biased advice, or can put patient privacy at risk. In healthcare, safety and ethics are very important, so avoiding harm to patients is a top priority.
Healthcare providers must build strong governance systems and risk management plans before using AI on a large scale. This means clear rules on data use, checking AI results by trained clinicians, and ongoing checks for errors or bias.
Dr. Javier Quintana Plaza, an expert in AI governance, says healthcare groups need systems that clearly describe who is in charge and set limits on how AI can be used in clinical and office tasks.
Generative AI requires advanced technology, like secure data storage, fast computing, and easy software connections. Many healthcare groups, especially small medical offices and local hospitals in the U.S., do not have enough IT resources or money to fully meet these needs.
Weak technology setups can slow down AI use or cause problems in clinical and office tasks. This can lower care quality and make operations less efficient. Improving infrastructure often needs teamwork with vendors and maybe help from government or private funding.
Healthcare in the U.S. has many strict rules about patient data privacy, decisions about treatment, and medical device approval. Generative AI must follow HIPAA rules to protect patient information and also follow Food and Drug Administration (FDA) guidance if used in diagnosis or treatment.
Because the rules are changing, healthcare groups must stay updated on these laws and work closely with legal and compliance teams to use AI in a lawful and ethical way.
Ethics also means avoiding bias against some patient groups and making sure AI recommendations are not followed without human clinical judgment.
Though nearly 60% of healthcare groups using generative AI say or expect positive ROI, many leaders are still cautious because measuring value is not always clear. Some benefits, like better doctor efficiency or more patient involvement, are hard to measure exactly.
Without solid proof of money and work benefits, groups hesitate to spend heavily on generative AI. Tests and pilot studies help build proof but need time and resources.
Make teams with doctors, IT workers, compliance officers, and managers to supervise AI use. These teams should set rules that include:
Organizations can learn from early users and experts like Chris Wayman, who stress the need for risk systems that support clear and ethical use of AI.
Since 59% of healthcare groups choose to work with outside vendors, picking partners with experience in healthcare is important. Custom AI solutions fit better with special clinical and office tasks.
Working with vendors also helps fix technology gaps by offering cloud platforms and technical help that smaller offices often lack.
To grow AI well, healthcare groups must update their IT systems. This includes:
Federal programs and grants may give money to help upgrade technology, especially for rural or communities with fewer health resources.
Many groups are still testing where generative AI is most useful with the least risk. A slow rollout, starting with office tasks before moving to clinical care, helps manage unknowns and allows learning along the way.
This also matches regulators’ preference for gradual changes with strong checks.
One useful feature of generative AI in healthcare is its ability to automate front-office and admin tasks. The company Simbo AI works on AI-powered phone automation and answering services for medical offices and healthcare groups in the U.S.
AI chatbots and voice assistants can handle patient phone calls automatically, freeing office staff to work on harder tasks. Automating appointment booking, reminders, and prescription refills cuts down waiting and mistakes in communication.
This kind of automation is very helpful in busy clinics where phone lines stay busy and staff are limited. AI can be available 24/7 and let patients get help anytime without extra cost.
Generative AI tools help doctors indirectly by reducing paperwork. Automating patient check-in or insurance tasks means doctors spend more time with patients.
Many healthcare leaders see better doctor productivity as one of the main benefits of generative AI. By using AI for workflow automation, groups can run more smoothly, lower doctor burnout, and make patients happier.
Good workflow automation needs AI tools to work closely with Electronic Health Records (EHR) and practice management systems. Custom AI tools ensure smooth data sharing, follow privacy rules, and give useful patient info to staff and doctors.
Vendor partnerships are important to offer these connected solutions. This is why almost 60% of healthcare groups prefer custom AI from skilled providers instead of ready-made products.
Generative AI has strong potential for improving clinical work, patient experience, and office efficiency. But its wide use in U.S. healthcare is still held back by worries about risks, technology problems, and rules. Medical office managers, owners, and IT leaders must plan carefully, focusing on strong governance, vendor partnerships, tech upgrades, and slow rollouts.
For workflow automation like phone systems and answering services, companies like Simbo AI show practical AI uses that boost communication and reduce office problems. These tools add clear value to healthcare groups wanting to lower admin work and improve patient contact.
As healthcare grows in its use of generative AI, U.S. groups need to balance new technology with careful risk control to make sure AI is safe, useful, and follows ethical standards in everyday care.
Over 70% of healthcare leaders report that their organizations are pursuing or have implemented generative AI capabilities, indicating a shift towards more active integration of this technology within the sector.
Most organizations are in the proof-of-concept stage, exploring the trade-offs among returns, risks, and strategic priorities before full implementation.
59% are partnering with third-party vendors, while 24% plan to build solutions in-house, suggesting a trend towards customized applications.
Risk concerns dominate, with 57% of respondents citing risks as a primary reason for delaying adoption.
Improvements in clinician productivity, patient engagement, administrative efficiency, and overall care quality are seen as key benefits.
While ROI is critical, most organizations have not yet evaluated it fully; approximately 60% of those who have implemented see or expect a positive ROI.
Major hurdles include risk management, technology readiness, insufficient infrastructure, and the challenge of proving value before further investment.
They allow organizations to leverage external expertise and develop tailored solutions, enhancing the ability to integrate generative AI effectively within existing systems.
Risks like inaccurate outputs and biases are crucial, necessitating strong governance, frameworks, and guardrails to ensure safety and regulatory compliance.
As organizations enhance their risk management and governance capabilities, a broader focus on core clinical applications is expected, ultimately improving patient experiences and care delivery.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
